Top Industry News
- EMA- Non-clinical documentation for herbal medicinal products in applications for marketing authorization (Updated)
- SFDA-Guideline on the scientific data requirements for Plasma Master File (PMF)
- FDA to Revise Pre-Submission draft guidance due to GDUFA II
- SFDA- Guidance for presenting PIL and Labeling information of Herbal and Health Products
- EMA- Strengthening EU-US cooperation in medicine inspections
- SFDA- Guideline on biosimilar products (Quality Considerations)
- SFDA- Guideline on Blood Products (Plasma Derived Medicinal Products)
- FDA Offers draft guidance to further secure drug supply chain